Medartis Holding AG (MED) Earnings Call Transcripts

Medartis Holding AG's Latest Earnings Call - June 4, 2026

In the second quarter of fiscal year 2026, Medartis Holding AG reported a strong performance driven by the successful launch of the TOUCH prosthesis in the U.S. The company achieved revenue growth of 16% year-over-year, reaching CHF 120 million, while EBITDA margins remained robust at 18%. Management maintained its full-year guidance for organic growth between 16% to 18%, signaling confidence in continued momentum, particularly in the U.S. market.

Reported metrics

Guidance from management

Management maintained its guidance for organic growth of 16% to 18% for the fiscal year 2026, emphasizing confidence in the U.S. market and continued expansion of the TOUCH product line.

What management said

Super excited about this. So this implant, it's been in Europe for a number of years. We're excited that it's now in the U.S. We're able to be the first institution in Florida to put it in old way of -- I shouldn't say old way, but we used to take out the bone and suspend it. So this just allows patients to kind of get moving a little bit quicker essentially. . [Presentation] .

So good morning, everybody. It's a big pleasure to be here and speak a little bit about innovation and what we're doing in our R&D departments all across the Medartis Group. [Presentation]

What analysts pressed on

Analysts raised concerns regarding the reimbursement landscape in the U.S., questioning the potential for pushback from insurance companies. There were also inquiries about the long-term adoption rates of the TOUCH prosthesis and the overall market dynamics in comparison to traditional procedures.

Main topics on the call

• U.S. Market Penetration — Management highlighted that the U.S. market is showing positive momentum with expectations for a minimum growth of 20%. They noted, "We see positive momentum. We see the gap closed in closing in Florida," indicating stro...
• TOUCH Prosthesis Adoption — The TOUCH prosthesis is gaining traction, with management stating, "May was the first month, we sold more than 150 TOUCH in the U.S." This suggests a solid ramp-up in adoption, with a target of 1,200 cases for the year.
• Production Capacity Expansion — Medartis is doubling its production facilities to meet increasing demand, with plans to produce 80% of U.S. products in Warsaw by 2027. Management stated, "Doubling the size of the production does not mean only doubling ...
• Employee Engagement and Culture — The company reported a record employee engagement score of 79%, indicating a positive shift in corporate culture. Management noted, "This is, by the way, the highest score you see Medartis had made in the history," refle...

Read the full Medartis Holding AG transcript (June 4, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 46 Medartis Holding AG earnings call transcripts on record, spanning January 13, 2020 to August 18, 2026. Based on this history, Medartis Holding AG reports quarterly. The most recent call on file is dated August 18, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

MED

Exchange

SWX

Country

CH

Sector

Health Care

Industry

Health Care Equipment and Supplies

Calls on record

46

First call

January 13, 2020

Most recent

August 18, 2026

Reporting cadence

quarterly